Combined inhibition of HER1/EGFR and RAC1 results in a synergistic antiproliferative effect on established and primary cultured human glioblastoma cells - Karpel-Massler, G; Westhoff, M-A; Zhou, S; Nonnenmacher, L; Dwucet, A; Kast, R E (Molecular Cancer Therapeutics, 2013)
et al.